-
1دورية أكاديمية
المؤلفون: Matthew R. Kroll, Cherry Au, Jessica Slostad, Trevor N. Christ, Sam G. Papas, Alan Tan
المصدر: Frontiers in Oncology, Vol 14 (2024)
مصطلحات موضوعية: precision oncology, BRAF/MEK inhibition, Wilms, rare tumors, BRAF V600E, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2024.1376270/fullTest; https://doaj.org/toc/2234-943XTest
-
2دورية أكاديمية
المؤلفون: Rossella Loria, Valentina Laquintana, Stefano Scalera, Rocco Fraioli, Valentina Caprara, Italia Falcone, Chiara Bazzichetto, Marta Di Martile, Laura Rosanò, Donatella Del Bufalo, Gianluca Bossi, Isabella Sperduti, Irene Terrenato, Paolo Visca, Silvia Soddu, Michele Milella, Gennaro Ciliberto, Rita Falcioni, Virginia Ferraresi, Giulia Bon
المصدر: Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-18 (2022)
مصطلحات موضوعية: Semaphorin SEMA6A, Melanoma, Dual BRAF/MEK inhibition, Actin cytoskeleton remodeling, YAP, Tumor microenvironment, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1756-9966Test
-
3دورية أكاديمية
المؤلفون: van Duin, Isabella A.J., Elias, Sjoerd G., van den Eertwegh, Alfonsus J.M., de Groot, Jan Willem B., Blokx, Willeke A.M., van Diest, Paul J., Leiner, Tim, Verhoeff, Joost J.C., Verheijden, Rik J., van Not, Olivier J., Aarts, Maureen J.B., van den Berkmortel, Franchette W.P.J., Blank, Christian U., Haanen, John B.A.G., Hospers, Geke A.P., Kamphuis, Anna M., Piersma, Djura, van Rijn, Rozemarijn S., van der Veldt, Astrid A.M., Vreugdenhil, Gerard, Wouters, Michel W.J.M., Stevense-den Boer, Marion A.M., Boers-Sonderen, Marye J., Kapiteijn, Ellen, Suijkerbuijk, Karijn P.M.
المساهمون: Hart- en Vaatziekten Team A, Epi Kanker Team C, Cancer, JC onderzoeksprogramma Kanker, Pathologie Pathologen staf, Pathologie, MS Radiologie, Circulatory Health, MS Radiotherapie, MS Medische Oncologie, Infection & Immunity
مصطلحات موضوعية: BRAF(/MEK) inhibition, immune checkpoint inhibition, immunotherapy, melanoma, prognosis, Oncology, Cancer Research, Journal Article
وصف الملف: application/pdf
-
4دورية أكاديمية
المؤلفون: Loria, Rossella, Laquintana, Valentina, Scalera, Stefano, Fraioli, Rocco, Caprara, Valentina, Falcone, Italia, Bazzichetto, Chiara, Di Martile, Marta, Rosanò, Laura, Del Bufalo, Donatella, Bossi, Gianluca, Sperduti, Isabella, Terrenato, Irene, Visca, Paolo, Soddu, Silvia, Milella, Michele, Ciliberto, Gennaro, Falcioni, Rita, Ferraresi, Virginia, Bon, Giulia
المساهمون: Loria, Rossella, Laquintana, Valentina, Scalera, Stefano, Fraioli, Rocco, Caprara, Valentina, Falcone, Italia, Bazzichetto, Chiara, Di Martile, Marta, Rosanò, Laura, Del Bufalo, Donatella, Bossi, Gianluca, Sperduti, Isabella, Terrenato, Irene, Visca, Paolo, Soddu, Silvia, Milella, Michele, Ciliberto, Gennaro, Falcioni, Rita, Ferraresi, Virginia, Bon, Giulia
مصطلحات موضوعية: Actin cytoskeleton remodeling, Dual BRAF/MEK inhibition, Melanoma, Semaphorin SEMA6A, Tumor microenvironment, YAP, Antineoplastic Combined Chemotherapy Protocols, Humans, Mitogen-Activated Protein Kinase Kinases, Mutation, Prognosis, Protein Kinase Inhibitors, Proto-Oncogene Proteins B-raf, rhoA GTP-Binding Protein, Semaphorins
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35440004; info:eu-repo/semantics/altIdentifier/wos/WOS:000784979600002; volume:41; issue:148; firstpage:1; lastpage:18; numberofpages:18; journal:JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH; http://hdl.handle.net/11562/1063632Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85128355658; https://jeccr.biomedcentral.com/articles/10.1186/s13046-022-02354-wTest
-
5
المؤلفون: Isabella A. J. van Duin, Sjoerd G. Elias, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, Willeke A. M. Blokx, Paul J. van Diest, Tim Leiner, Joost J. C. Verhoeff, Rik J. Verheijden, Olivier J. van Not, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Christian U. Blank, John B. A. G. Haanen, Geke A. P. Hospers, Anna M. Kamphuis, Djura Piersma, Rozemarijn S. van Rijn, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Marion A. M. Stevense‐den Boer, Marye J. Boers‐Sonderen, Ellen Kapiteijn, Karijn P. M. Suijkerbuijk
المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), Radiology & Nuclear Medicine
المصدر: van Duin, I A J, Elias, S G, van den Eertwegh, A J M, de Groot, J W B, Blokx, W A M, van Diest, P J, Leiner, T, Verhoeff, J J C, Verheijden, R J, van Not, O J, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Haanen, J B A G, Hospers, G A P, Kamphuis, A M, Piersma, D, van Rijn, R S, van der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M, Stevense-den Boer, M A M, Boers-Sonderen, M J, Kapiteijn, E & Suijkerbuijk, K P M 2023, ' Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma ', International Journal of Cancer, vol. 152, no. 12, pp. 2493-2502 . https://doi.org/10.1002/ijc.34479Test
International Journal of Cancer, 152(12), 2493-2502. Wiley
International Journal of Cancer, 152(12), 2493-2502. Wiley-Liss Inc.مصطلحات موضوعية: Mitogen-Activated Protein Kinase Kinases, Cancer Research, Oncology, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Proto-Oncogene Proteins B-raf/genetics, BRAF(/MEK) inhibition, melanoma, SURVIVAL, Humans, immune checkpoint inhibition, immunotherapy, prognosis, Retrospective Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6899fe47da203e306ee373387a5e2107Test
https://doi.org/10.1002/ijc.34479Test -
6دورية أكاديمية
المؤلفون: Emily J. Lelliott, Grant A. McArthur, Jane Oliaro, Karen E. Sheppard
المصدر: Frontiers in Immunology, Vol 12 (2021)
مصطلحات موضوعية: melanoma, targeted therapeutic drugs, immunotherapy, CDK4/6 inhibition, BRAF/MEK inhibition, immune checkpoint blockade, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fimmu.2021.661737/fullTest; https://doaj.org/toc/1664-3224Test
-
7دورية أكاديمية
المؤلفون: Katharina C. Kähler, Ralf Gutzmer, Friedegrund Meier, Lisa Zimmer, Markus Heppt, Anja Gesierich, Kai-Martin Thoms, Jochen Utikal, Jessica C. Hassel, Carmen Loquai, Claudia Pföhler, Lucie Heinzerling, Martin Kaatz, Daniela Göppner, Annette Pflugfelder, Ann-Sophie Bohne, Imke Satzger, Lydia Reinhardt, Jan-Malte Placke, Dirk Schadendorf, Selma Ugurel
المصدر: Frontiers in Oncology, Vol 11 (2021)
مصطلحات موضوعية: melanoma, vemurafenib, cobimetinib, BRAF/MEK inhibition, skin toxicity, therapy outcome, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2021.672172/fullTest; https://doaj.org/toc/2234-943XTest
-
8دورية أكاديمية
المؤلفون: Sidsel Pedersen (11582661), Kirstine Ostenfeld Larsen (11582664), Alex Hørby Christensen (11582667), Inge Marie Svane (7902218), Bo Zerahn (263026), Eva Ellebaek (11582670)
مصطلحات موضوعية: Medicine, Molecular Biology, Developmental Biology, Cancer, Mental Health, Hematology, Infectious Diseases, Biological Sciences not elsewhere classified, BRAF/MEK inhibition, cardiotoxicity, malignant melanoma, equilibrium radionuclide angiography, multigated acquisition
-
9دورية أكاديمية
المؤلفون: Bisschop, C., de Heer, E. C., Brouwers, A. H., Hospers, G. A.P., Jalving, M.
المصدر: Bisschop , C , de Heer , E C , Brouwers , A H , Hospers , G A P & Jalving , M 2020 , ' Rational use of 18 F-FDG PET/CT in patients with advanced cutaneous melanoma : A systematic review ' , Critical Reviews in Oncology/Hematology , vol. 153 , 103044 . https://doi.org/10.1016/j.critrevonc.2020.103044Test
مصطلحات موضوعية: F-FDG, F-fluorodeoxyglucose, BRAF(/MEK) inhibition, Imaging, Immunotherapy, Melanoma, PET/CT, Positron emission tomography
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1016/j.critrevonc.2020.103044Test
https://hdl.handle.net/11370/fdd98100-f940-4b03-a77c-fa5fbbc884faTest
https://research.rug.nl/en/publications/fdd98100-f940-4b03-a77c-fa5fbbc884faTest
https://pure.rug.nl/ws/files/130258057/1_s2.0_S1040842820301815_main.pdfTest -
10دورية أكاديمية
المؤلفون: Duin, I.A.J. van, Elias, S.G., Eertwegh, A.J.M. van den, Groot, J.W.B. de, Blokx, W.A.M., Diest, P.J. van, Leiner, T., Verhoeff, J.J.C., Verheijden, R.J., Not, O.J. van, Aarts, M.J.B., Berkmortel, F.W.P.J. van den, Blank, C.U., Haanen, J.B.A.G., Hospers, G.A.P., Kamphuis, A.M., Piersma, D., Rijn, R.S. van, Veldt, A.A.M. van der, Vreugdenhil, G., Wouters, M.W.J.M., Stevense-den Boer, M.A.M., Boers-Sonderen, M.J., Kapiteijn, E., Suijkerbuijk, K.P.M.
المصدر: International Journal of Cancer
مصطلحات موضوعية: BRAF(/MEK) inhibition, immune checkpoint inhibition, immunotherapy, melanoma, prognosis
وصف الملف: application/pdf
العلاقة: lumc-id: 185206300; https://hdl.handle.net/1887/3753837Test